Your browser doesn't support javascript.
loading
Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis.
Quiroga, Dionisia; Liebner, David A; Philippon, Jennifer S; Hoffman, Sarah; Tan, Yubo; Chen, James L; Lenobel, Scott; Wakely, Paul E; Pollock, Raphael; Tinoco, Gabriel.
Afiliação
  • Quiroga D; The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA.
  • Liebner DA; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Starling Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.
  • Philippon JS; The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA.
  • Hoffman S; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Starling Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.
  • Tan Y; Department of Biomedical Informatics, The Ohio State University, 250 Lincoln Tower, 1800 Cannon Dr, Columbus, OH, 43210, USA.
  • Chen JL; The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA.
  • Lenobel S; The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA.
  • Wakely PE; Center for Biostatistics, The Ohio State University, 2012 Kenny Rd, Columbus, OH, 43221, USA.
  • Pollock R; The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA.
  • Tinoco G; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Starling Loving Hall, 320 W 10th Ave, Columbus, OH, 43210, USA.
BMC Cancer ; 20(1): 527, 2020 Jun 05.
Article em En | MEDLINE | ID: mdl-32503455

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos